Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Franklin BSP Realty Trust (FBRT) To Contact Him Directly To Discuss Their Options If you purchased or acquired securities between November 5, 2024 and February 11, 2026 in Franklin BSP Realty Trust and would like to discuss your legal rights, call Bragar Eagel & Squire partner Brandon Walker or Melissa Fortunato directly at (212) 355-4648. Click here to participate in the action. NEW YORK, Feb. 26, 2026 ...

To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh. ...

Core Insights - Financial software firm Intuit exceeded estimates for its fiscal second quarter but provided mixed guidance for the current quarter, leading to a decline in its stock price [1] Company Performance - Intuit reported strong performance in its fiscal second quarter, surpassing analyst expectations [1] - Despite the strong quarterly results, the guidance for the upcoming quarter was not as optimistic, contributing to a drop in stock value [1] Market Reaction - Following the mixed guidance, Intuit's stock experienced a decline, indicating investor concerns about future performance [1]

Shrinking the central bank's holdings isn't as simple as expanding them in an emergency was. ...

If you are interested in keeping up to date with stocks making moves within the biotech, pharma and healthcare industries, and understanding the key trends and catalysts driving valuations ahead of the market, why not subscribe to my weekly newsletter via my Investing Group, Haggerston BioHealth ?Edmund Ingham is a biotech consultant. He has been covering biotech, healthcare, and pharma for over 5 years, and has put together detailed reports of over 1,000 companies. He leads the investing group Haggerston B ...

The technology company recorded a 39% jump in sales, driven in part by growth in its AI server business, and anticipates growth will continue into the new fiscal year. ...

Group 1 - The article promotes a weekly newsletter focused on stocks in the biotech, pharma, and healthcare industries, highlighting key trends and catalysts that influence market valuations [1] - Edmund Ingham, a biotech consultant with over 5 years of experience, leads the Haggerston BioHealth investing group, which caters to both novice and experienced investors [1] - The investing group provides insights such as buy and sell ratings, product sales forecasts for major pharmaceutical companies, integrated financial statements, discounted cash flow analysis, and market-specific analyses [1]

Group 1 - The company recorded a 39% increase in sales, attributed in part to growth in its AI server business [1] - The company anticipates that growth will continue into the new fiscal year [1]

About this content About Angela Harmantas Angela Harmantas is an Editor at Proactive. She has over 15 years of experience covering the equity markets in North America, with a particular focus on junior resource stocks. Angela has reported from numerous countries around the world, including Canada, the US, Australia, Brazil, Ghana, and South Africa for leading trade publications. Previously, she worked in investor relations and led the foreign direct investment program in Canada for the Swedish government ...

US consumer debt continued its upward climb through the end of 2025, with growth gaining momentum in the final months of the year, according to Equifax’s (NYSE: EFX) National Market Pulse report released February 24, 2026. The credit analytics firm’s proprietary data shows total consumer debt balances reached $18.20 trillion by December, up 3.7% from a year earlier—the sharpest monthly acceleration compared to the same periods in 2023 and 2024.This figure aligns with broader measures from the Federal Reserv ...